Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
B. Metzler seel. Sohn & Co. AG reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 26.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,969 shares of the biopharmaceutical company’s stock after selling 2,104 shares […]
Cascade Investment Advisors Inc. cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,259 shares of the biopharmaceutical company’s stock after selling 45 shares during the period. Regeneron Pharmaceuticals […]
Citizens Financial Group Inc RI lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,625 shares of the biopharmaceutical company’s stock after selling 327 shares during the quarter. Citizens Financial […]
Magnus Financial Group LLC increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,516 shares of the biopharmaceutical company’s stock after purchasing an additional 15 shares during the quarter. Magnus Financial […]
Magnus Financial Group LLC raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,516 shares of the biopharmaceutical company’s stock after purchasing an additional 15 shares during the […]